Primary care providers (PCPs) manage a large portion of patients with diabetes. Continuous glucose monitoring (CGM) can give detailed information about glucose trends to improve treatment and safety. We conducted a prospective cohort pilot study to understand patient experience with the use of professional CGM in a primary care practice with a high volume of diverse, non-English speakers. Eligible patients were on an insulin regimen and either had an A1c above goal or whose PCPs had concerns for hypoglycemia. Surveys were collected prior to the intervention to assess the acceptability of the patient's self-monitoring blood glucose efforts and after the intervention to assess their experience of using the CGM. Participants at baseline had a mean A1c of 10.6% and a high amount of emotional distress as measured on the Problem Areas in Diabetes (PAID) scale. Post-intervention, patients reported their experience with professional CGM was positive and, overall, as acceptable of an intervention as their previous self-monitoring blood glucose practice. Professional CGM can serve as an additional, acceptable tool for PCPs to better understand how to help patients achieve diabetes blood glucose goals. Ambulatory care pharmacists are well positioned to lead this effort in clinics.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836751 | PMC |
http://dx.doi.org/10.24926/iip.v13i2.4784 | DOI Listing |
J Diabetes Sci Technol
January 2025
Clinical and Biomedical Sciences, University of Exeter, Exeter, UK.
Horm Res Paediatr
December 2024
of what is New or Different 1. This chapter recommends a target HbA1c of ≤6.5% (48mmol/mol) for those who have access to advanced diabetes technologies like continuous glucose monitoring (CGM) and automated insulin delivery (AID).
View Article and Find Full Text PDFAims: This expert consensus reviews the reality of primary care clinical management of people with type 2 diabetes (T2D) on non-intensive insulin therapy, with an emphasis on the use of continuous glucose monitoring (CGM) technology for effective care in this participant group. Here, we identify key unmet needs for skills and systems development within this frontline healthcare setting, along with major challenges and opportunities associated with managing these changes effectively.
Methods: The authors participated in two primary care consensus panels held on 28 November 2023 and on 21 May 2024.
BMJ Open
December 2024
Department of General Practice, Sorbonne Université, Paris, France
Background: Social determinants of health (SDH) impact the health status of individuals around the world. General practitioners (GPs) can take into account the social situation of patients in their care practice. To this end, the College of General Medicine (CGM) issued recommendations in 2022 to propose 100 methods of action.
View Article and Find Full Text PDFInt J Sport Nutr Exerc Metab
December 2024
Performance and Medical Department, VF Group-Bardiani-CSF-Faizanè Professional Cycling Team, Reggio Emilia, Italy.
This observational study investigated the use of continuous glucose monitoring (CGM) in a team of professional cyclists without diabetes during two consecutive annual training camps. The goal of the study was twofold: to present the aggregated CGM metrics such as day/overnight CGM average (DAYAVG/OVNAVG) for this group of professional cyclists and to study the association between exercise energy expenditure (megajoules per day), carbohydrate intake (grams), and minimum overnight CGM values (millimoles per liter). Linear mixed models were employed in the analysis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!